Affymax Inc (AFFY) financial statements (2023 and earlier)

Company profile

Business Address 19200 STEVENS CREEK BOULEVARD
CUPERTINO, CA 94014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5,59777,982
Cash and cash equivalents5,59768,265
Short-term investments 9,717
Receivables 18,365
Advances on inventory purchases 17,800
Prepaid expense and other current assets7255,800
Other undisclosed current assets (17,437)
Total current assets:6,322102,510
Noncurrent Assets
Property, plant and equipment 2,981
Long-term investments and receivables 2,323
Long-term investments 2,323
Restricted cash and investments 1,135
Prepaid expense and other noncurrent assets1,1212,392
Other undisclosed noncurrent assets 6,876
Total noncurrent assets:1,12115,707
TOTAL ASSETS:7,443118,217
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities68271,950
Accounts payable1016,591
Accrued liabilities58152,522
Employee-related liabilities 12,837
Debt 8,844
Other undisclosed current liabilities8,18918,281
Total current liabilities:8,87199,075
Noncurrent Liabilities
Liabilities, other than long-term debt 10,848
Liability for uncertainty in income taxes 10,062
Restructuring reserve (13)
Other liabilities 799
Other undisclosed noncurrent liabilities 13
Total noncurrent liabilities: 10,861
Total liabilities:8,871109,936
Stockholders' equity
Stockholders' equity attributable to parent(1,428)8,281
Common stock3737
Additional paid in capital556,672551,959
Accumulated other comprehensive loss (2)
Accumulated deficit(558,137)(543,713)
Total stockholders' equity:(1,428)8,281
TOTAL LIABILITIES AND EQUITY:7,443118,217

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Revenues
(Revenue, Net)
1,36994,370
Gross profit:1,36994,370
Operating expenses(16,415)(186,409)
Operating loss:(15,046)(92,039)
Nonoperating income2943
Investment income, nonoperating2177
Other nonoperating income (expense)8(34)
Interest and debt expense(1,565)(1,442)
Loss from continuing operations before income taxes:(16,582)(93,438)
Income tax benefit2,15826
Net loss available to common stockholders, diluted:(14,424)(93,412)

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net loss:(14,424)(93,412)
Other comprehensive income (loss)2(20)
Comprehensive loss, net of tax, attributable to parent:(14,422)(93,432)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: